Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Advitech
company
About
Advitech researches, develops, and commercializes nutraceutical ingredients and products to prevent immune-mediated inflammatory disorders.
- 11 - 50
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $2.51M
- Industries
- Biotechnology,Developer Platform,Nutraceutical
- Founded date
- Jan 1, 1997
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Advitech is a life science and technology company with the mission to discover and commercialize patented, scientifically supported natural health products. Effective and safe, these products target immune system disorders, such as psoriasis and inflammatory bowel disease. Advitech produces Dermylex (R) for the treatment of mild to moderate psoriasis. Advitech has developed a research program to develop new applications in the field of wound healing. This development program stems from the two technological platforms XP-828L and IM.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$2.51M
Advitech has raised a total of
$2.51M
in funding over 2 rounds. Their latest funding was raised on
Nov 26, 2009 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 26, 2009 | Series Unknown | $2.51M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Advitech is funded by 1 investors.
AgeChem Venture Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
AgeChem Venture Fund
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
